S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.49 (+1.26%)
AAPL   235.32 (-0.23%)
FB   188.83 (+3.03%)
MSFT   141.56 (+1.44%)
GOOGL   1,242.48 (+2.03%)
AMZN   1,768.17 (+1.83%)
MU   46.46 (+3.54%)
BABA   175.32 (+2.43%)
GE   8.88 (+1.83%)
T   37.92 (+1.20%)
F   9.08 (+2.83%)
ACB   3.76 (+7.13%)
PRI   123.70 (+1.84%)
NFLX   284.25 (-0.45%)
BAC   29.76 (+2.09%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.49 (+1.26%)
AAPL   235.32 (-0.23%)
FB   188.83 (+3.03%)
MSFT   141.56 (+1.44%)
GOOGL   1,242.48 (+2.03%)
AMZN   1,768.17 (+1.83%)
MU   46.46 (+3.54%)
BABA   175.32 (+2.43%)
GE   8.88 (+1.83%)
T   37.92 (+1.20%)
F   9.08 (+2.83%)
ACB   3.76 (+7.13%)
PRI   123.70 (+1.84%)
NFLX   284.25 (-0.45%)
BAC   29.76 (+2.09%)
Log in

Avanos Medical Stock Price, News & Analysis (NYSE:AVNS)

$39.22
+0.18 (+0.46 %)
(As of 10/15/2019 04:00 PM ET)
Today's Range
$39.08
Now: $39.22
$39.84
50-Day Range
$32.28
MA: $36.03
$39.82
52-Week Range
$31.78
Now: $39.22
$62.48
Volume17,499 shs
Average Volume340,306 shs
Market Capitalization$1.87 billion
P/E Ratio47.84
Dividend YieldN/A
Beta1.53
Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-428-2667

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$652.30 million
Cash Flow$1.51 per share
Book Value$27.35 per share

Profitability

Net Income$57.50 million

Miscellaneous

Employees4,700
Market Cap$1.87 billion
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable

Receive AVNS News and Ratings via Email

Sign-up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.


Avanos Medical (NYSE:AVNS) Frequently Asked Questions

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

How were Avanos Medical's earnings last quarter?

Avanos Medical Inc (NYSE:AVNS) released its quarterly earnings results on Tuesday, August, 6th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.03. The firm earned $172.20 million during the quarter, compared to the consensus estimate of $172.02 million. Avanos Medical had a negative net margin of 3.92% and a positive return on equity of 4.18%. The company's revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.20 EPS. View Avanos Medical's Earnings History.

When is Avanos Medical's next earnings date?

Avanos Medical is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Avanos Medical.

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical issued an update on its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share (EPS) guidance of $1.15-1.25 for the period, compared to the Thomson Reuters consensus estimate of $1.23.

What price target have analysts set for AVNS?

6 Wall Street analysts have issued twelve-month price targets for Avanos Medical's shares. Their forecasts range from $45.00 to $69.00. On average, they anticipate Avanos Medical's stock price to reach $54.80 in the next year. This suggests a possible upside of 39.7% from the stock's current price. View Analyst Price Targets for Avanos Medical.

What is the consensus analysts' recommendation for Avanos Medical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.

Has Avanos Medical been receiving favorable news coverage?

News articles about AVNS stock have trended neutral recently, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Avanos Medical earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Avanos Medical.

Who are some of Avanos Medical's key competitors?

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Honeywell International (HON), CVS Health (CVS), Workday (WDAY), Baxter International (BAX), IHS Markit (INFO), Kimberly Clark (KMB), Nike (NKE), Veeva Systems (VEEV), Westinghouse Air Brake Technologies (WAB) and AlarmCom (ALRM).

Who are Avanos Medical's key executives?

Avanos Medical's management team includes the folowing people:
  • Mr. Joseph F. Woody, CEO & Director (Age 53)
  • Mr. John W. Wesley, Sr. VP of Legal & Gov. Relations (Age 60)
  • Mr. John R. Tushar, Pres of Global Franchises (Age 57)
  • Mr. Arjun Ranjan Sarker, Sr. VP of International (Age 53)
  • Mr. Warren J. MacHan, Sr. VP of Bus. Strategy & Interim CFO (Age 53)

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Pacer Advisors Inc. (0.04%), State of Alaska Department of Revenue (0.02%), Gateway Investment Advisers LLC (0.02%) and North Star Investment Management Corp. (0.01%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.

Which major investors are selling Avanos Medical stock?

AVNS stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC and Pacer Advisors Inc.. View Insider Buying and Selling for Avanos Medical.

Which major investors are buying Avanos Medical stock?

AVNS stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue and North Star Investment Management Corp.. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.

How do I buy shares of Avanos Medical?

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $39.22.

How big of a company is Avanos Medical?

Avanos Medical has a market capitalization of $1.87 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.

What is Avanos Medical's official website?

The official website for Avanos Medical is http://www.halyardhealth.com/.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]


MarketBeat Community Rating for Avanos Medical (NYSE AVNS)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  63 (Vote Underperform)
Total Votes:  112
MarketBeat's community ratings are surveys of what our community members think about Avanos Medical and other stocks. Vote "Outperform" if you believe AVNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel